Welcome to the First 2017 Issue of The CLL Tribune
This issue of The CLL Tribune is our 7th quarterly newsletter and I am proud to say it marks two years since the CLL Society has had a web presence. We have only grown because of your support. Thank you.
This issue includes our Basic section where I do the math on how much CLL we have in our blood. In Beyond the Basics, Dr. Pagel discusses the rapidly changing role of transplant in CLL. From ASH 2016, in Conference Coverage, Dr. Seymour discusses promising new BTK inhibitors. I hope you enjoy my Did You Know fun CLL facts and please don’t skip our Ask & Tell section where you can read the results of last issue’s Reader Poll or Ask the Doctor section featuring Dr. Furman.
The Living Well with CLL section has five amazing and inspiring articles all written by patients: CLL Life Lessons by Jennifer Woolf; A Sentence of Life! By Derek Caine; Me and my Leukemia, BFFs Forever by Nancy O’Brien Simpson; n of 1 Chapter 28 by Glenn Sabin with my brief intro; and a book review of n of 1 Book by Rick Conner.
We can learn so much from each other. We are so grateful to all our contributors and for your readership and support that in two short years has made us the go-to site for patient-friendly education, support and research. And please, if you have a story to tell or a lesson to share, we need you to write for us. Reach out to us at support@CLLSociety.org.
Stay strong. Stay in touch. We are all in this together.
Brian Koffman, MD
Medical Director, CLL Society
By Brian Koffman, MD
I was asked what seems as if it should be a simple question: What can one tell about our cancer load in CLL (chronic lymphocytic leukemia) from the common and dirt-cheap…Read more
Stem Cell Transplantation in Chronic Lymphocytic Leukemia: Who, What, When and Why Aren’t More Patients Transplanted?
By John Pagel, MD PhD
Those who treat chronic lymphocytic leukemia (CLL) are commonly asked if we can cure the disease. It is what every patient wants to know. The majority of patients are told…Read more
By Richard Furman, MD
As a CLL/SLL patient, what other illnesses am I more inclined to have based on my compromised immune of the system? There are several diseases CLL patients are more…Read more
By Brian Koffman, MD and John Seymour, MD
Professor John Seymour of Peter MacCallum Cancer Centre in Melbourne, Australia describes two new BTK inhibitors beyond ibrutinib in our short interview at the 2016…Read The Interview
We’d like to thank the supporters of The CLL Tribune:
- Genentech/Biogen Idec
- Sunesis Pharmaceuticals
- TEVA Pharmaceuticals
- TG Therapeutics
The CLL Society does not provide medical advice or endorsements. Unless explicitly stated otherwise, all content in the CLL Tribune is the opinion or information of its author, not the CLL Society. This newsletter is for reference and educational purposes only and is not a substitute for medical advice. We do not guarantee the accuracy of any of the materials. Always contact your own doctor or other professional healthcare provider if you have any questions concerning your or your family’s health. Everyone’s circumstances are different.